Telcoin Association has appointed David Palmer, co-founder of Pairpoint, as Strategic Telecom Advisor to guide mobile operator adoption and ecosystem growth. Palmer brings over 25 years of telecom experience and will support onboarding mobile operators and mobile-money providers as Telcoin Network prepares for a mainnet launch in 2026. The Telcoin Network is a blockchain secured by GSMA mobile operators, aiming to extend trusted communication networks to money transactions. This move strengthens Telcoin's position in integrating telecom standards with blockchain technology.
Telcoin Association's appointment of David Palmer as Strategic Telecom Advisor is presented here with Pluang's market data for context. As of Oct 13, 2026 21:51 WIB, among 50 major cryptocurrencies priced on Pluang, 15 rose and 34 fell. Notable price movements include ZIL at Rp62 with a 1-day change of -5.88% and a Pluang order activity of 82% Sell, CRV at Rp6.117 down 5.62% with 91% Buy activity, and XTZ at Rp6.037 up 5.12%.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
